Case-control studies of the southern Chinese population found the C-allele at rs9296559 of CD2AP to be associated with the risk of sporadic AD and suggested decreased expression of CD2AP in peripheral blood lymphocytes of AD patients as a potential biomarker (Tao et al., 2017). This evidence concerns the gene CD2AP and Alzheimer disease.